nach oben

Erschienen in:

17.05.2020 | Original Article

Association between changes in bioactive osteocalcin and glucose homeostasis after biliopancreatic diversion

verfasst von: Anne-Frédérique Turcotte, Thomas Grenier-Larouche, Julie Lacombe, Anne-Marie Carreau, André C. Carpentier, Fabrice Mac-Way, André Tchernof, Denis Richard, Laurent Biertho, Stefane Lebel, Simon Marceau, Mathieu Ferron, Claudia Gagnon

Erschienen in: Endocrine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bone may regulate glucose homeostasis via uncarboxylated bioactive osteocalcin (ucOCN). This study explored whether changes in ucOCN and bone remodeling are associated with change in glucose homeostasis after biliopancreatic diversion (BPD).

Methods

In this secondary exploratory analysis of a 1-year prospective observational study, 16 participants (11 men/5 women; 69% with type 2 diabetes; mean BMI 49.4 kg/m²) were assessed before, 3 days, 3 months and 12 months after BPD. Changes in plasma ucOCN and bone markers (C-terminal telopeptide (CTX), total osteocalcin (OCN)) were correlated with changes in insulin resistance or sensitivity indices (HOMA-IR; adipose tissue insulin resistance index (ADIPO-IR) and insulin sensitivity index (SI) from the hyperinsulinemic-euglycemic clamp), insulin secretion rate (ISR) from the hyperglycemic clamp, and disposition index (DI: SI × ISR) using Spearman correlations before and after adjustment for weight loss.

Results

ucOCN was unchanged at 3 days but increased dramatically at 3 months (+257%) and 12 months (+498%). Change in ucOCN correlated significantly with change in CTX at 3 months (r = 0.62, p = 0.015) and 12 months (r = 0.64, p = 0.025) before adjustment for weight loss. It also correlated significantly with change in fasting insulin (r = −0.53, p = 0.035), HOMA-IR (r = −0.54, p = 0.033) and SI (r = 0.52, p = 0.041) at 3 days, and ADIPO-IR (r = −0.69, p = 0.003) and HbA_1c (r = −0.69, p = 0.005) at 3 months. Change in OCN did not correlate with any glucose homeostasis indices. Results were similar after adjustment for weight loss.

Conclusion

The increase in ucOCN may be associated with the improvement in insulin resistance after BPD, independently of weight loss. These findings need to be confirmed in larger, less heterogeneous populations.

G. Mingrone, S. Panunzi, A. De Gaetano, C. Guidone, A. Iaconelli, L. Leccesi, G. Nanni, A. Pomp, M. Castagneto, G. Ghirlanda, F. Rubino, Bariatric surgery versus conventional medical therapy for type 2 diabetes. N. Engl. J. Med. 366(17), 1577–1585 (2012). https://doi.org/10.1056/NEJMoa1200111CrossRefPubMed

H. Buchwald, R. Estok, K. Fahrbach, D. Banel, M.D. Jensen, W.J. Pories, J.P. Bantle, I. Sledge, Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am. J. Med. 122(3), 248–256.e245 (2009). https://doi.org/10.1016/j.amjmed.2008.09.041CrossRefPubMed

H. Buchwald, Y. Avidor, E. Braunwald, M.D. Jensen, W. Pories, K. Fahrbach, K. Schoelles, Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14), 1724–1737 (2004). https://doi.org/10.1001/jama.292.14.1724CrossRefPubMed

C. Guidone, M. Manco, E. Valera-Mora, A. Iaconelli, D. Gniuli, A. Mari, G. Nanni, M. Castagneto, M. Calvani, G. Mingrone, Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55(7), 2025–2031 (2006). https://doi.org/10.2337/db06-0068CrossRefPubMed

A. Michaud, T. Grenier-Larouche, D. Caron-Dorval, S. Marceau, L. Biertho, S. Simard, D. Richard, A. Tchernof, A.C. Carpentier, Biliopancreatic diversion with duodenal switch leads to better postprandial glucose level and beta cell function than sleeve gastrectomy in individuals with type 2 diabetes very early after surgery. Metab.: Clin. Exp. 74, 10–21 (2017). https://doi.org/10.1016/j.metabol.2017.06.005CrossRef

T. Grenier-Larouche, A.M. Carreau, A. Geloen, F. Frisch, L. Biertho, S. Marceau, S. Lebel, F.S. Hould, D. Richard, A. Tchernof, A.C. Carpentier, Fatty acid metabolic remodeling during type 2 diabetes remission after bariatric surgery. Diabetes 66(11), 2743–2755 (2017). https://doi.org/10.2337/db17-0414CrossRefPubMed

T. Grenier-Larouche, A.M. Carreau, A.C. Carpentier, Early metabolic improvement after bariatric surgery: the first steps toward remission of type 2 diabetes. Can. J. Diabetes 41(4), 418–425 (2017). https://doi.org/10.1016/j.jcjd.2016.10.013CrossRefPubMed

C.E. Plourde, T. Grenier-Larouche, D. Caron-Dorval, S. Biron, S. Marceau, S. Lebel, L. Biertho, A. Tchernof, D. Richard, A.C. Carpentier, Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction. Obesity 22(8), 1838–1846 (2014). https://doi.org/10.1002/oby.20771CrossRefPubMed

C. Koliaki, S. Liatis, C.W. le Roux, A. Kokkinos, The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr. Disord. 17(1), 50 (2017). https://doi.org/10.1186/s12902-017-0202-6CrossRefPubMedPubMedCentral

10.

G. Karsenty, M. Ferron, The contribution of bone to whole-organism physiology. Nature 481(7381), 314–320 (2012). https://doi.org/10.1038/nature10763CrossRefPubMedPubMedCentral

11.

P. Mera, M. Ferron, I. Mosialou, Regulation of energy metabolism by bone-derived hormones. Cold Spring Harbor Perspect. Med. (2017). https://doi.org/10.1101/cshperspect.a031666

12.

N.K. Lee, H. Sowa, E. Hinoi, M. Ferron, J.D. Ahn, C. Confavreux, R. Dacquin, P.J. Mee, M.D. McKee, D.Y. Jung, Z. Zhang, J.K. Kim, F. Mauvais-Jarvis, P. Ducy, G. Karsenty, Endocrine regulation of energy metabolism by the skeleton. Cell 130(3), 456–469 (2007). https://doi.org/10.1016/j.cell.2007.05.047CrossRefPubMedPubMedCentral

13.

M. Ferron, E. Hinoi, G. Karsenty, P. Ducy, Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl Acad. Sci. USA 105(13), 5266–5270 (2008). https://doi.org/10.1073/pnas.0711119105CrossRefPubMedPubMedCentral

14.

J. Lacombe, G. Karsenty, M. Ferron, In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice. Mol. Metab. 2(4), 498–504 (2013). https://doi.org/10.1016/j.molmet.2013.08.004CrossRefPubMedPubMedCentral

15.

J. Bonneau, G. Ferland, A.D. Karelis, E. Doucet, M. Faraj, R. Rabasa-Lhoret, M. Ferron, Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women. J. Diabetes Complicat. 31(6), 1027–1034 (2017). https://doi.org/10.1016/j.jdiacomp.2017.01.023CrossRef

16.

U. Razny, D. Fedak, B. Kiec-Wilk, J. Goralska, A. Gruca, A. Zdzienicka, M. Kiec-Klimczak, B. Solnica, A. Hubalewska-Dydejczyk, M. Malczewska-Malec, Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes. Diabetes/Metab. Res. Rev. 33(3), (2017). https://doi.org/10.1002/dmrr.2862

17.

Y. Takashi, M. Koga, Y. Matsuzawa, J. Saito, M. Omura, T. Nishikawa, Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes. J. Diabetes Investig. 8(4), 471–474 (2017). https://doi.org/10.1111/jdi.12601CrossRefPubMedPubMedCentral

18.

Q. Guo, H. Li, L. Xu, S. Wu, H. Sun, B. Zhou, Undercarboxylated osteocalcin reverts insulin resistance induced by endoplasmic reticulum stress in human umbilical vein endothelial cells. Sci. Rep. 7(1), 46 (2017). https://doi.org/10.1038/s41598-017-00163-2CrossRefPubMedPubMedCentral

19.

D.M. Liu, X.Z. Guo, H.J. Tong, B. Tao, L.H. Sun, H.Y. Zhao, G. Ning, J.M. Liu, Association between osteocalcin and glucose metabolism: a meta-analysis. Osteoporos. Int. 26(12), 2823–2833 (2015). https://doi.org/10.1007/s00198-015-3197-8CrossRefPubMed

20.

A.F. Turcotte, T. Grenier-Larouche, R.V. Ung, D. Simonyan, A.M. Carreau, A.C. Carpentier, F. Mac-Way, L. Michou, A. Tchernof, L. Biertho, S. Lebel, S. Marceau, C. Gagnon, Effects of biliopancreatic diversion on bone turnover markers and association with hormonal factors in patients with severe obesity. Obes. Surg. 29(3), 990–998 (2019). https://doi.org/10.1007/s11695-018-3617-xCrossRefPubMed

21.

J. Lacombe, O. Al Rifai, L. Loter, T. Moran, A.F. Turcotte, T. Grenier-Larouche, A. Tchernof, L. Biertho, A.C. Carpentier, D. Prud'homme, R. Rabasa-Lhoret, G. Karsenty, C. Gagnon, W. Jiang, M. Ferron, Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and beta-cell function. Am. J. Physiol. Endocrinol. Metab. 318(3), E381–E391 (2020). https://doi.org/10.1152/ajpendo.00321.2019CrossRefPubMedPubMedCentral

22.

Standards of Medical Care in Diabetes, Abridged for Primary Care Providers. Clin. Diabetes Publ. Am. Diabetes Assoc. 35(1), 5–26 (2017). https://doi.org/10.2337/cd16-0067

23.

L. Biertho, S. Lebel, S. Marceau, F.S. Hould, F. Julien, S. Biron, Biliopancreatic diversion with duodenal switch: surgical technique and perioperative care. Surg. Clin. N. Am. 96(4), 815–826 (2016). https://doi.org/10.1016/j.suc.2016.03.012CrossRefPubMed

24.

D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed

25.

E. Sondergaard, A.E. Espinosa De Ycaza, M. Morgan-Bathke, M.D. Jensen, How to measure adipose tissue insulin sensitivity. J. Clin. Endocrinol. Metab. 102(4), 1193–1199 (2017). https://doi.org/10.1210/jc.2017-00047CrossRefPubMedPubMedCentral

26.

A.C. Carpentier, F. Frisch, D. Cyr, P. Genereux, B.W. Patterson, R. Giguere, J.P. Baillargeon, On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am. J. Physiol. Endocrinol. Metab. 289(5), E849–E856 (2005). https://doi.org/10.1152/ajpendo.00073.2005CrossRefPubMed

27.

A. Carpentier, S.D. Mittelman, B. Lamarche, R.N. Bergman, A. Giacca, G.F. Lewis, Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am. J. Physiol. 276(6 Pt 1), E1055–E1066 (1999)PubMed

28.

R.N. Bergman, M. Ader, K. Huecking, G. Van Citters, Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51(Suppl 1), S212–S220 (2002)CrossRefPubMed

29.

S.E. Kahn, The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46(1), 3–19 (2003). https://doi.org/10.1007/s00125-002-1009-0CrossRefPubMed

30.

M. Ferron, J. Lacombe, Regulation of energy metabolism by the skeleton: osteocalcin and beyond. Arch. Biochem. Biophysics 561, 137–146 (2014). https://doi.org/10.1016/j.abb.2014.05.022CrossRef

31.

A. Diaz-Lopez, M. Bullo, M. Juanola-Falgarona, M.A. Martinez-Gonzalez, R. Estruch, M.I. Covas, F. Aros, J. Salas-Salvado, Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study. J. Clin. Endocrinol. Metab. 98(11), 4524–4531 (2013). https://doi.org/10.1210/jc.2013-2472CrossRefPubMed

32.

K. Mori, M. Emoto, K. Motoyama, E. Lee, S. Yamada, T. Morioka, Y. Imanishi, T. Shoji, M. Inaba, Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus. Diabetol. Metab. Syndr. 4(1), 53 (2012). https://doi.org/10.1186/1758-5996-4-53CrossRefPubMedPubMedCentral

33.

R. Saucedo, G. Rico, G. Vega, L. Basurto, L. Cordova, R. Galvan, M. Hernandez, E. Puello, A. Zarate, Osteocalcin, under-carboxylated osteocalcin and osteopontin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women. J. Endocrinol. Investig. 38(5), 519–526 (2015). https://doi.org/10.1007/s40618-014-0220-4CrossRef

34.

M. Ferron, J. Wei, T. Yoshizawa, A. Del Fattore, R.A. DePinho, A. Teti, P. Ducy, G. Karsenty, Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142(2), 296–308 (2010). https://doi.org/10.1016/j.cell.2010.06.003CrossRefPubMedPubMedCentral

35.

B. Lee, J. Shao, Adiponectin and energy homeostasis. Rev. Endocr. Metab. Disord. 15(2), 149–156 (2014). https://doi.org/10.1007/s11154-013-9283-3CrossRefPubMedPubMedCentral

36.

R. Ye, P.E. Scherer, Adiponectin, driver or passenger on the road to insulin sensitivity? Mol. Metab. 2(3), 133–141 (2013). https://doi.org/10.1016/j.molmet.2013.04.001CrossRefPubMedPubMedCentral

37.

X. Wu, H. Motoshima, K. Mahadev, T.J. Stalker, R. Scalia, B.J. Goldstein, Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52(6), 1355–1363 (2003)CrossRefPubMed

38.

J.J. Cao, Effects of obesity on bone metabolism. J. Orthop. Surg. Res. 6, 30 (2011). https://doi.org/10.1186/1749-799x-6-30CrossRefPubMedPubMedCentral

39.

B.A. Gower, K. Casazza, Divergent effects of obesity on bone health. J. Clin. Densitom. 16(4), 450–454 (2013). https://doi.org/10.1016/j.jocd.2013.08.010CrossRefPubMedPubMedCentral

40.

A.L. Evans, M.A. Paggiosi, R. Eastell, J.S. Walsh, Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J. Bone Miner. Res. 30(5), 920–928 (2015). https://doi.org/10.1002/jbmr.2407CrossRefPubMed

41.

J.S. Walsh, T. Vilaca, Obesity, type 2 diabetes and bone in adults. Calcif. Tissue Int. 100(5), 528–535 (2017). https://doi.org/10.1007/s00223-016-0229-0CrossRefPubMedPubMedCentral

42.

J. Wei, M. Ferron, C.J. Clarke, Y.A. Hannun, H. Jiang, W.S. Blaner, G. Karsenty, Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J. Clin. Investig. 124(4), 1–13 (2014). https://doi.org/10.1172/jci72323CrossRefPubMed

43.

C. Gagnon, A.L. Schafer, Bone health after bariatric surgery. JBMR 2(3), 121–133 (2018). https://doi.org/10.1002/jbm4.10048CrossRef

44.

C. Rousseau, S. Jean, P. Gamache, S. Lebel, F. Mac-Way, L. Biertho, L. Michou, C. Gagnon, Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ (Clin. Res. ed.) 354, i3794 (2016). https://doi.org/10.1136/bmj.i3794CrossRef

45.

E.W. Yu, M. Wewalka, S.A. Ding, D.C. Simonson, K. Foster, J.J. Holst, A. Vernon, A.B. Goldfine, F. Halperin, Effects of gastric bypass and gastric banding on bone remodeling in obese patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 101(2), 714–722 (2016). https://doi.org/10.1210/jc.2015-3437CrossRefPubMed

46.

R. Basu, J. Peterson, R. Rizza, S. Khosla, Effects of physiological variations in circulating insulin levels on bone turnover in humans. J. Clin. Endocrinol. Metab. 96(5), 1450–1455 (2011). https://doi.org/10.1210/jc.2010-2877CrossRefPubMedPubMedCentral

47.

M.M. Weivoda, C.K. Chew, D.G. Monroe, J.N. Farr, E.J. Atkinson, J.R. Geske, B. Eckhardt, B. Thicke, M. Ruan, A.J. Tweed, L.K. McCready, R.A. Rizza, A. Matveyenko, M. Kassem, T.L. Andersen, A. Vella, M.T. Drake, B.L. Clarke, M.J. Oursler, S. Khosla, Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nat. Commun. 11(1), 87 (2020). https://doi.org/10.1038/s41467-019-14003-6CrossRefPubMedPubMedCentral

48.

I. Mosialou, S. Shikhel, J.M. Liu, A. Maurizi, N. Luo, Z. He, Y. Huang, H. Zong, R.A. Friedman, J. Barasch, P. Lanzano, L. Deng, R.L. Leibel, M. Rubin, T. Nickolas, W. Chung, L.M. Zeltser, K.W. Williams, J.E. Pessin, S. Kousteni, MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543(7645), 385–390 (2017). https://doi.org/10.1038/nature21697CrossRefPubMedPubMedCentral

49.

S. Costantini, C. Conte, Bone health in diabetes and prediabetes. World J. Diabetes 10(8), 421–445 (2019). https://doi.org/10.4239/wjd.v10.i8.421CrossRefPubMedPubMedCentral

50.

F. Gossiel, H. Altaher, D.M. Reid, C. Roux, D. Felsenberg, C.C. Gluer, R. Eastell, Bone turnover markers after the menopause: T-score approach. Bone 111, 44–48 (2018). https://doi.org/10.1016/j.bone.2018.03.016CrossRefPubMed

Titel: Association between changes in bioactive osteocalcin and glucose homeostasis after biliopancreatic diversion
verfasst von: Anne-Frédérique Turcotte
Thomas Grenier-Larouche
Julie Lacombe
Anne-Marie Carreau
André C. Carpentier
Fabrice Mac-Way
André Tchernof
Denis Richard
Laurent Biertho
Stefane Lebel
Simon Marceau
Mathieu Ferron
Claudia Gagnon
Publikationsdatum: 17.05.2020
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02340-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Trends in long-term glucocorticoid use and risk of 5-year mortality: a historical cohort study in South Korea

MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives

Cell proliferation, apoptosis, and angiogenesis in non-functional pituitary adenoma: association with tumor invasiveness

Differential effects of metformin on reductive activity and energy production in pituitary tumor cells compared to myogenic precursors

Magnetic resonance imaging has an advantage over conventional spine X-rays in the evaluation of rebound-associated vertebral fractures following denosumab discontinuation